CompaniesByCap
PRTA
Prothena Corporation plc (PRTA)
NASDAQ · Healthcare

Prothena Corporation plc Revenue 2012–2025

Prothena Corporation plc annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Prothena Corporation plc revenue for the quarter ending March 31, 2026 was 51.1 M, a 1706.36% increase year-over-year.
  • Prothena Corporation plc revenue for the twelve months ending March 31, 2026 was 60.7 M, a 72.12% decrease year-over-year.
  • Prothena Corporation plc annual revenue for 2025 was 9.7 M, a 92.83% decrease from 2024.
  • Prothena Corporation plc annual revenue for 2024 was 135.2 M, a 47.92% increase from 2023.
  • Prothena Corporation plc annual revenue for 2023 was 91.4 M, a 69.50% increase from 2022.
  • Prothena Corporation plc annual revenue for 2022 was 53.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Prothena Corporation plc (PRTA) — Frequently Asked Questions

Prothena Corporation plc (PRTA) is a publicly traded US company. It has a market capitalization of $448M. In fiscal 2025 it reported revenue of $10M and net income of -$244M. Explore PRTA's stock price, financial statements, earnings history, margins and key ratios below.

What is Prothena Corporation plc's market cap?

Prothena Corporation plc (PRTA) has a market capitalization of $448M.

What is the PRTA stock price?

PRTA trades at $8.33 (+5.31% on the day).

How much revenue does Prothena Corporation plc make?

Prothena Corporation plc reported revenue of $10M in fiscal 2025.

Is PRTA profitable?

In fiscal 2025, Prothena Corporation plc reported net income of -$244M.